Epigenetic changes of CDX2 in gastric adenocarcinoma
- 319 Downloads
Gastric cancer is one of the most commonplace and lethal cancers in the world. Molecular investigation of this disease, in order to obtain diagnostic and treatments achievements is important and vital. Relatively, in this research study, one of the most important epigenetic factors, the methylation of CDX2 gene was investigated in tumoral and non-tumoral tissues of gastric cancer patients by bisulfite treatment followed by sequencing of the 5’UTR region of CDX2 in both tissues. The results indicated a hypomethylation in tumoral tissues of adenocarcinoma. Consequently, the methylation amount of CDX2 in tumoral tissues was significantly reduced compared with non-tumoral tissues.
KeywordsMethylation Gastric cancer UTR CDX2
Compliance with ethical standards
Conflict of interest
The authors declare no conflict of interest.
- Esteller M, Toyota M, Sanchez-Cespedes M, Capella G, Peinado MA, Watkins DN, Issa JP, Sidransky D, Baylin SB, Herman JG (2000) Inactivation of the DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hypermethylation is associated with G to a mutations in K-ras in colorectal tumorigenesis. Cancer Res 60:2368–2371PubMedGoogle Scholar
- Nikbakhsh N, Shafahi S, Taheri H, Samadani AA, Noroullahi SE, Pilecian M, Saromeh SH, Kolagar A, Ghasemzadeh M, Esmailzadeh Tahmtan S (2016) Histopathological investigation in gastric cancer. J Int Res Med Pharm Sci 8:52–56Google Scholar
- Schneider BG, Peng DF, Camargo MC, Piazuelo MB, Sicinschi LA, Mera R, Romero-Gallo J, Delgado AG, Bravo LE, Wilson KT, Peek RM Jr, Correa P, El-Rifai W (2010) Promoter DNA hypermethylation in gastric biopsies from subjects at high and low risk for gastric cancer. Int J Cancer 127(11):2588–2597CrossRefPubMedPubMedCentralGoogle Scholar